HIV preventive vaccines. Progress to date (Q40961265)

25 September 2017

1 reference

title

HIV preventive vaccines. Progress to date (English)

1 reference

25 September 2017

J Esparza

1

1 reference

25 September 2017

S Osmanov

series ordinal

2

1 reference

25 September 2017

W L Heyward

series ordinal

3

1 reference

25 September 2017

publication date

1 November 1995

1 reference

25 September 2017

1 reference

25 September 2017

volume

50

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

792-804

1 reference

Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes

25 September 2017

cites work

1 reference

12 December 2020

Alloimmunization to prevent AIDS?

1 reference

12 December 2020

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines

1 reference

12 December 2020

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

1 reference

12 December 2020

1 reference

12 December 2020

Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.

1 reference

12 December 2020

Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

1 reference

12 December 2020

Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype

1 reference

12 December 2020

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

1 reference

12 December 2020

Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccine.

1 reference

12 December 2020

HIV with multiple gene deletions as a live attenuated vaccine for AIDS.

1 reference

12 December 2020

Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses

1 reference

12 December 2020

Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus.

1 reference

12 December 2020

Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.

1 reference

12 December 2020

Vaccines against human immunodeficiency virus--progress and prospects

1 reference

12 December 2020

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

1 reference

12 December 2020

The role of upstream U3 sequences in the pathogenesis of simian immunodeficiency virus-induced AIDS in rhesus monkeys.

1 reference

12 December 2020

Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects

1 reference

12 December 2020

The serologic significance of F viral genotype for human immunodeficiency virus type 1 epidemic

1 reference

12 December 2020

Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization

1 reference

12 December 2020

Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization

1 reference

12 December 2020

Multifactorial nature of human immunodeficiency virus disease: implications for therapy

1 reference

12 December 2020

Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera

1 reference

12 December 2020

Engineering poliovirus as a vaccine vector for the expression of diverse antigens

1 reference

12 December 2020

Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network.

1 reference

12 December 2020

Cytokine patterns during the progression to AIDS

1 reference

12 December 2020

Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen

1 reference

12 December 2020

Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study.

1 reference

12 December 2020

Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO Network for HIV Isolation and Characterization

1 reference

12 December 2020

Vaccinology, immunology, and comparative pathogenesis of measles in the quest for a preventative against AIDS.

1 reference

12 December 2020

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

1 reference

12 December 2020

Use of new vectors for the development of vaccines.

1 reference

12 December 2020

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

12 December 2020

Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and C

1 reference

12 December 2020

A strategy for prophylactic vaccination against HIV.

1 reference

12 December 2020

Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate

1 reference

12 December 2020

Non-progression in HIV infection

1 reference

12 December 2020

Cross-neutralizing antibodies to HIV-1ANT70 and HIV-1IIIB in sera of African and Belgian HIV-1-infected individuals

1 reference

12 December 2020

Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Nucleic Acid Vaccines, WHO, Geneva, 17-18 May 1994

1 reference

12 December 2020

HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. WHO Network for HIV Isolation and Characterization

1 reference

12 December 2020

NIH conference. HIV vaccine development: a progress report

1 reference

12 December 2020

Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1

1 reference

12 December 2020

Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization

1 reference

12 December 2020

Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network

1 reference

12 December 2020

Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers

1 reference

12 December 2020

Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes

1 reference

12 December 2020

Planning for HIV vaccine trials: the World Health Organization perspective

1 reference

12 December 2020

Feasibility of developing live attenuated HIV vaccines: conclusions and recommendations. World Health Organization Working Group

1 reference

12 December 2020

A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon

1 reference

12 December 2020

Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion

1 reference

12 December 2020

Human immunodeficiency virus infection among high-risk seronegative prostitutes in Nairobi

1 reference

12 December 2020

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

12 December 2020

HIV infection in vaccinated volunteers.

1 reference

12 December 2020

Serological responses to candidate AIDS vaccines

1 reference

12 December 2020

Annual updated survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.

1 reference

12 December 2020

Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans

1 reference

12 December 2020

Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype

1 reference

12 December 2020

Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting

1 reference

12 December 2020

Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results

1 reference

12 December 2020

Scientific and public health rationale for HIV vaccine efficacy trials. World Health Organization

1 reference

12 December 2020

AIDS vaccines. Will media reports KO upcoming real-life trials?

1 reference

12 December 2020

Human CD4+ cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 subunit vaccine

1 reference

12 December 2020

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

12 December 2020

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

1 reference

12 December 2020

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

1 reference

12 December 2020

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

12 December 2020

Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.

1 reference

12 December 2020

Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers

1 reference

12 December 2020

HIV pathogenesis and long-term survival

1 reference

12 December 2020

Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil.

1 reference

12 December 2020

Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies

1 reference

12 December 2020

Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression.

1 reference

12 December 2020

Gene inoculation generates immune responses against human immunodeficiency virus type 1

1 reference

12 December 2020

Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries

1 reference

12 December 2020

Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network

1 reference

12 December 2020

Anti-cell antibody in macaques

1 reference

12 December 2020

Nonhuman primate models for AIDS.

1 reference

12 December 2020

Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene.

1 reference

12 December 2020

The immunopathogenesis of human immunodeficiency virus infection

1 reference

12 December 2020

Protection from HIV infection or AIDS?

1 reference

12 December 2020

Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines

1 reference

12 December 2020

AIDS vaccines. Are we ready for human efficacy trials?

1 reference

12 December 2020

Slowing the spread of HIV: agenda for the 1990s

1 reference

12 December 2020

Persisting human immunodeficiency virus type 1 gp160-specific human T lymphocyte responses including CD8+ cytotoxic activity after receipt of envelope vaccines

1 reference

12 December 2020

Preparation for phase III HIV vaccine efficacy trials: methods for the determination of HIV incidence

1 reference

12 December 2020

Long-term HIV-1 infection without immunologic progression

1 reference

12 December 2020

Rapid genetic characterization of HIV type 1 strains from four World Health Organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. WHO Network for HIV Isolation and Characterization

1 reference

12 December 2020

Anti-HIV vaccines. Current status and future developments

1 reference

12 December 2020

The World Health Organization Network for HIV Isolation and Characterization: summary of a pilot study

1 reference

12 December 2020

The World Health Organization Global Programme on AIDS proposal for standardization of HIV sequence nomenclature. WHO Network for HIV Isolation and Characterization

1 reference

12 December 2020

Cell-mediated immunity in HIV infection.

1 reference

12 December 2020

Alloimmunization as an AIDS vaccine?

1 reference

12 December 2020

AIDS Research Shifts to Immunity

1 reference

12 December 2020

Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine

1 reference

12 December 2020

A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1

1 reference

12 December 2020

Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine

1 reference

12 December 2020

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

1 reference

12 December 2020

Nucleic acid immunization: a prophylactic gene therapy?

1 reference

12 December 2020

Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells

1 reference

12 December 2020

Standard conditions of virus isolation reveal biological variability of HIV type 1 in different regions of the world. WHO Network for HIV Isolation and Characterization

1 reference

12 December 2020

AIDS vaccines. At conference, hope for success is further attenuated

1 reference

12 December 2020

AIDS vaccine research. U.S. panel votes to delay real-world vaccine trials

1 reference

12 December 2020

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

1 reference

12 December 2020

Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines

1 reference

12 December 2020

HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood

1 reference

12 December 2020

Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.

1 reference

12 December 2020

Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire

1 reference

12 December 2020

Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections

1 reference

12 December 2020

Scientific and social issues of human immunodeficiency virus vaccine development

1 reference

12 December 2020

Resistance to HIV infection

1 reference

12 December 2020

Antibodies to V3 loop peptides derived from chimpanzee lentiviruses and the divergent HIV-1ANT-70 isolate in human sera from different geographic regions

1 reference

12 December 2020

Comparison of the immune response to recombinant gp120 in humans and chimpanzees

1 reference

12 December 2020

Regulatory considerations for nucleic acid vaccines

1 reference

12 December 2020

Safety considerations for nucleic acid vaccines

1 reference

12 December 2020

Behavioral research contributions to planning and conducting HIV vaccine efficacy studies

1 reference

12 December 2020

Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies

1 reference

12 December 2020

Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin

1 reference

12 December 2020

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody

1 reference

12 December 2020

Lessons from people with nonprogressive HIV infection

1 reference

12 December 2020

Reexamining AIDS research priorities

1 reference

12 December 2020

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

12 December 2020

Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.

1 reference

12 December 2020

AIDS vaccine research. A new goal: preventing disease, not infection

1 reference

12 December 2020

HIV Type 1 Variation in World Health Organization-Sponsored Vaccine Evaluation Sites: Genetic Screening, Sequence Analysis, and Preliminary Biological Characterization of Selected Viral Strains

1 reference

12 December 2020

10.2165/00003495-199550050-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

25 September 2017

1008052487

0 references

1 reference